Major surgery management in patients with haemophilia A and inhibitors on emicizumab prophylaxis without global coagulation monitoring

被引：13
作者：
Biron-Andreani, Christine [1 ,2 ]
Diaz-Cau, Isabelle [2 ]
Ranc, Alexandre [2 ]
Navarro, Robert [1 ]
Leonardi, Christian [3 ]
Dischino, Marion [3 ]
Guy, Romuald [4 ]
Theron, Alexandre [1 ]
Garcia-Gournay, Corinne [1 ,2 ]
Santagostino, Elena [5 ]
Schved, Jean-Francois [2 ]
机构：
[1] Univ Hosp, Hemophilia Treatment Ctr, Montpellier, France
[2] Univ Hosp, Dept Haematol, Montpellier, France
[3] Clin Franciscaines, Dept Surg, Nimes, France
[4] Clin Castelet, Dept Phys Reeduc, Montpellier, France
[5] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2020年 / 189卷 / 03期
关键词：
emicizumab; major surgery; haemophilia A; inhibitors; THROMBIN GENERATION ASSAY; FACTOR-VIII;
D O I：
10.1111/bjh.16512
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E100 / E103
页数：4
相关论文
共 12 条
[1]   Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors [J].
Abshire, T. ;
Kenet, G. .
HAEMOPHILIA, 2008, 14 (05) :898-902
[2]   Treatment of bleeding episodes in haemophilia A complicated by a factor VIII inhibitor in patients receiving Emicizumab. Interim guidance from UKHCDO Inhibitor Working Party and Executive Committee [J].
Collins, P. W. ;
Liesner, R. ;
Makris, M. ;
Talks, K. ;
Chowdary, P. ;
Chalmers, E. ;
Hall, G. ;
Riddell, A. ;
Percy, C. L. ;
Hay, C. R. ;
Hart, D. P. .
HAEMOPHILIA, 2018, 24 (03) :344-347
[3]   Use of thrombin generation assay to personalize treatment of breakthrough bleeds in a patient with hemophilia and inhibitors receiving prophylaxis with emicizumab [J].
Dargaud, Yesim ;
Lienhart, Anne ;
Janbain, Maissaa ;
Le Quellec, Sandra ;
Enjolras, Nathalie ;
Negrier, Claude .
HAEMATOLOGICA, 2018, 103 (04) :E181-E183
[4]   Spanish consensus guidelines on prophylaxis with bypassing agents for surgery in patients with haemophilia and inhibitors [J].
Eva Mingot-Castellano, Maria ;
Teresa Alvarez-Roman, Maria ;
Fernanda Lopez-Fernandez, Maria ;
Altisent-Roca, Carmen ;
Isabel Canaro-Hirnyk, Mariana ;
Jimenez-Yuste, Victor ;
Rosa Cid-Haro, Ana ;
Perez-Garrido, Rosario ;
Sedano-Balbas, Carmen .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (05) :461-474
[5]   European principles of inhibitor management in patients with haemophilia [J].
Giangrande, P. L. F. ;
Hermans, C. ;
O'Mahony, B. ;
de Kleijn, P. ;
Bedford, M. ;
Batorova, A. ;
Blatny, J. ;
Jansone, K. .
ORPHANET JOURNAL OF RARE DISEASES, 2018, 13
[6]   Management of perioperative hemostasis in a severe hemophilia A patient with inhibitors on emicizumab using global hemostasis assays [J].
Kizilocak, Hande ;
Yukhtman, Clara Lana ;
Marquez-Casas, Elizabeth ;
Lee, Jeanie ;
Donkin, Jennifer ;
Young, Guy .
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2019, 10 :1-9
[7]  
Kruse-Jarres R, 2017, BLOOD, V130
[8]   Low thrombin generation during major orthopaedic surgery fails to predict the bleeding risk in inhibitor patients treated with bypassing agents [J].
Mancuso, M. E. ;
Chantarangkul, V. ;
Clerici, M. ;
Fasulo, M. R. ;
Padovan, L. ;
Scalambrino, E. ;
Peyvandi, F. ;
Tripodi, A. ;
Santagostino, E. .
HAEMOPHILIA, 2016, 22 (04) :E292-E300
[9]   Thrombin Generation Assay as a Laboratory Monitoring Tool during Bypassing Therapy in Patients with Hemophilia and Inhibitors [J].
Mancuso, Maria Elisa ;
Fasulo, Maria Rosaria .
SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2016, 42 (01) :30-35
[10]   Emicizumab Prophylaxis in Hemophilia A with Inhibitors [J].
Oldenburg, Johannes ;
Mahlangu, Johnny N. ;
Kim, Benjamin ;
Schmitt, Christophe ;
Callaghan, Michael U. ;
Young, Guy ;
Santagostino, Elena ;
Kruse-Jarres, Rebecca ;
Negrier, Claude ;
Kessler, Craig ;
Valente, Nancy ;
Asikanius, Elina ;
Levy, Gallia G. ;
Windyga, Jerzy ;
Shima, Midori .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (09) :809-818
12